30273P1
Transfusion Products of Conception, Circulatory to Nonautologous with Frozen Red Cells, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 3 Administration |
| Body System | 0 Circulatory |
| Operation | 2 Transfusion |
| Body Part | 7 Products of Conception, Circulatory |
| Approach | 3 Percutaneous |
| Device | P Frozen Red Cells |
| Qualifier | 1 Nonautologous |
Operation Definition
Putting in blood or blood products
Procedure Overview
Transfusion is the administration of blood or a blood-derived product directly into a patient's circulation, most commonly packed red blood cells, platelets, fresh frozen plasma, or cryoprecipitate. It is used to treat significant blood loss, severe anemia, clotting disorders, or shortages of specific blood components caused by disease or treatment such as chemotherapy.
For a patient, a transfusion means receiving donated or, less commonly, their own previously collected blood through an intravenous line. The goal is to quickly restore oxygen-carrying capacity, clotting ability, or blood volume when the body cannot do so on its own. Transfusions are generally short procedures performed at the bedside, though the underlying condition prompting them can range from routine surgical blood loss to a life-threatening hemorrhage.
Anatomy & Axis Detail
Products of Conception, Circulatory
Products of conception, circulatory, refers to transfusion delivered into the fetal or placental circulation rather than the mother's own vasculature, most often performed as an intrauterine transfusion for severe fetal anemia such as that caused by Rh alloimmunization or parvovirus infection. The procedure requires ultrasound-guided needle access into the umbilical vein or, less commonly, the fetal peritoneal cavity, making it technically distinct from any transfusion into maternal vessels. Because the fetus is the recipient, precise blood typing, irradiation, and volume calculation based on gestational age and fetal weight are critical to avoid volume overload or cardiac compromise. Documentation must clearly identify the fetal circulatory target rather than the mother's vein, since misclassification would obscure the fact that the products of conception, not the pregnant patient, received the transfused substance.
Approach: Percutaneous
In Administration, Percutaneous denotes a substance delivered by needle injection through the skin, such as an intramuscular or subcutaneous injection, without cutting or scope guidance. It differs from External, where the substance is applied to the skin surface itself, and from Via Natural or Artificial Opening, where it is introduced through an orifice rather than through a puncture.
Substance: Frozen Red Cells
Frozen Red Cells are erythrocytes cryopreserved with glycerol, typically reserved for patients with rare blood types, alloantibodies, or for long-term stockpiling such as military or disaster reserves. Before infusion they must be thawed and deglycerolized, a step not required for standard Red Blood Cells. This code applies specifically when the frozen/deglycerolized product, rather than routine packed cells, is administered.
Qualifier: Nonautologous
This Administration qualifier marks a transfused substance, usually blood or a blood product, as coming from a donor other than the patient. It is the general counterpart to Autologous, and is further broken down elsewhere by donor relationship into related and unrelated allogeneic sources for certain transfusion products such as bone marrow or stem cells.
Coding & Documentation
Assigning a code from this family depends on documentation specifying the exact blood product given, whether it was autologous or from a donor, and the vessel or route used for infusion, such as a peripheral vein or central venous catheter. Nursing and physician notes recording units transfused, product type, and any reaction are the primary support for the code. A recurring error is selecting the wrong substance qualifier, for example coding platelets when frozen plasma was actually given, or overlooking that autologous blood requires a different qualifier than banked donor blood. Coders should also confirm the route matches what is documented rather than defaulting to peripheral vein.